NEUPERT PETER M
SEC Form 4 insider trading activity
NEUPERT PETER M has filed 4 SEC Form 4 filings (7 transaction rows) across 3 companies, including ADPT, FTRE, LH, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, NEUPERT PETER M is listed as Director at Adaptive Biotechnologies Corp. Inside the rolling window, NEUPERT PETER M reported no open-market purchases and 1 open-market sale totaling $3.1M in ADPT.
Companies traded
Other insiders at ADPT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.1M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has NEUPERT PETER M made?
NEUPERT PETER M has filed 4 SEC Form 4 filings (7 transaction rows) across 3 companies, including ADPT, FTRE, LH since 2026.
Which companies does NEUPERT PETER M trade?
NEUPERT PETER M has filed SEC Form 4 disclosures for 3 companies, including ADPT, FTRE, LH.
When was NEUPERT PETER M's most recent SEC Form 4 filing?
NEUPERT PETER M's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is NEUPERT PETER M's total buy and sell value in the current window?
Inside the rolling retention window, NEUPERT PETER M bought $0 and sold $3.1M based on SEC Form 4 filings.
What was NEUPERT PETER M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 124,690 ADPT shares on 2026-08-17, worth $3.1M, per SEC Form 4 filings.